Search

Author/Creator Creekmore, Stephen P

1. CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells. (4th November 2015)

Authors:
Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook E; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin C; Sondel, Paul M; Wakelee, Heather A; Apodaca, Minjun C; Fling, Steven P; Disis, Mary L; Creekmore, Stephen P; Miller, Jeffrey S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells. (6th November 2014)

Authors:
Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin; M Sondel, Paul; Wakelee, Heather; Disis, Mary L; Creekmore, Stephen P; Miller, Jeffrey S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search